RNA
10 drugs Oncology
10
approved indications
10
Approved Drugs
9
Companies
22
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (9 companies)
✓ All 10 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (22 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
AZURITY 2 drugs
AYANA PHARMA LTD 1 drug
Baxter 1 drug
By Therapeutic Area
Oncology 7 drugs
Other 3 drugs
Drugs by Company PRO
AYANA PHARMA LTD 1 drug
Baxter 1 drug
PENN LIFE 1 drug
AVET LIFESCIENCES 1 drug
Fresenius Kabi 1 drug
SETON PHARMS 1 drug
CARNEGIE 1 drug
EPIC PHARMA LLC 1 drug
By Therapeutic Area
Oncology 7 drugs
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL), DOXIL (LIPOSOMAL), CARMUSTINE, BICNU +3 more
Other 3 drugs
PENTAM, PENTAMIDINE ISETHIONATE, EPIRUBICIN HYDROCHLORIDE
Indications Treated
Pneumocystis jiroveci PneumoniaKaposi's SarcomaBrain TumorGlioblastomaBrainstem GliomaMedulloblastomaAstrocytomaEpendymomaMultiple MyelomaHodgkin's LymphomaNon-Hodgkin's LymphomaBreast CancerAcute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaHodgkin LymphomaNon-Hodgkin LymphomaWilms' TumorNeuroblastomaSoft Tissue SarcomaBone SarcomaOvarian CarcinomaGlioma
All Drugs Targeting RNA
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) Top | AYANA PHARMA LTD | 2013 | 10 | Oncology |
| DOXIL (LIPOSOMAL) Top | Baxter | 1995 | 10 | Oncology |
| CARMUSTINE Top | PENN LIFE | 2018 | 9 | Oncology |
| BICNU | AVET LIFESCIENCES | 1977 | 9 | Oncology |
| PENTAM | Fresenius Kabi | 1984 | 2 | |
| PENTAMIDINE ISETHIONATE | SETON PHARMS | 1992 | 2 | |
| LOMUSTINE | CARNEGIE | 2025 | 2 | Oncology |
| GLEOSTINE | AZURITY | 1976 | 2 | Oncology |
| GLIADEL | AZURITY | 1996 | 2 | Oncology |
| EPIRUBICIN HYDROCHLORIDE | EPIC PHARMA LLC | 2006 | - |